Exploring cognitive biases in people bereaved by violent death

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the cognitive and neurophysiological processes in individuals who have recently lost a loved one to violent death, such as homicide or suicide. It aims to identify attentional biases and changes in temporal perception that may contribute to the development of post-traumatic stress disorder and depression. Participants will undergo behavioral assessments and electroencephalography to measure their cognitive responses to threatening stimuli. The research seeks to enhance understanding of the unique challenges faced by this population and the potential early indicators of psychiatric complications.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* An age between 18 and 65 years old
* Recent bereavement by violent death of a relative in first and second degree

Exclusion Criteria:

* Protected adults
* Lack of mastering French language
* History of neurodegenerative disorder
* History of psychiatric disorder treated pharmacologically with modification of the basic treatment in the month preceding the death
* The take of an benzodiazepine treatment in the 24th hours before the first visit (T0)

Where it's running

• Hopital Vinatier
  Bron, France Recruiting

Study contacts

• Principal investigator: Edouard LEAUNE — Vinatier Hospital
• Study coordinator: Laurene LESTIENNE
• Email: laurene.lestienne@ch-le-vinatier.fr
• Phone: 0033437915120

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Anger, Social Thinking, and PTSD in French Veterans

  This study tests whether PTSD in former French military personnel is linked to higher anger through changes in social thinking abilities.

  Recruiting Direction Centrale du Service de Santé des Armées · Draguignan · NCT07851090

• TSND-201 treatment for PTSD in adults

  This study tests two doses of TSND-201 or placebo to see if it helps adults with PTSD.

  Recruiting at 9 sites Phase 3 Transcend Therapeutics · Denver, Colorado and 8 other locations · NCT07836647

• Long-term outcomes after Hyperbaric Oxygen Therapy in veterans with TBI, PCS, or PTSD

  This study tests whether benefits from HBOT persist over time for veterans with brain injury or related conditions.

  Recruiting Phase 2 Summit Hyperbarics and Wellness · Boise, Idaho · NCT07732374

• SEE FAR CBT for Adults With PTSD

  This 12-week, one-on-one SEE FAR CBT program tests a trauma-focused therapy to see if PTSD symptoms improve in adults 18 and older.

  Recruiting Community Stress Prevention Center · Kiryat Shmona · NCT07720674

• Brief SEE FAR CBT: a short, focused therapy for adults with PTSD

  A 6-session Brief SEE FAR CBT treatment is tested against usual dynamic psychotherapy for adults with PTSD to see if it reduces symptoms.

  Recruiting Community Stress Prevention Center · Sha'ar Hanegev · NCT07710573

• MDMA Therapy for PTSD in Veterans

  This phase 2 study tests a fixed 120 mg dose of MDMA, followed by a 60 mg supplemental dose, plus therapy, to see if it helps adults who are veterans with PTSD.

  Recruiting Phase 2 Sunstone Medical · Rockville, Maryland · NCT07569159

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.